Skip Nav Destination
Issues
1 July 2004
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Advances in Brief
Topical Tazarotene Chemoprevention Reduces Basal Cell Carcinoma Number and Size in Ptch1+/− Mice Exposed to Ultraviolet or Ionizing Radiation
Po-Lin So; Kenneth Lee; Jennifer Hebert; Patricia Walker; Ying Lu; Jimmy Hwang; Levy Kopelovich; Mohammed Athar; David Bickers; Michelle Aszterbaum; Ervin H. Epstein, Jr.
Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing Akt
Lin Yang; Han C. Dan; Mei Sun; Qiyuan Liu; Xia-meng Sun; Richard I. Feldman; Andrew D. Hamilton; Mark Polokoff; Santo V. Nicosia; Meenhard Herlyn; Said M. Sebti; Jin Q. Cheng
Accumulation of the Oxidative Base Lesion 8-Hydroxyguanine in DNA of Tumor-Prone Mice Defective in Both the Myh and Ogg1 DNA Glycosylases
Maria Teresa Russo; Gabriele De Luca; Paolo Degan; Eleonora Parlanti; Eugenia Dogliotti; Deborah E. Barnes; Tomas Lindahl; Hanjing Yang; Jeffrey H. Miller; Margherita Bignami
Molecular Biology, Pathobiology, and Genetics
Genomic DNA-Chip Hybridization Reveals a Higher Incidence of Genomic Amplifications in Pancreatic Cancer than Conventional Comparative Genomic Hybridization and Leads to the Identification of Novel Candidate Genes
Karlheinz Holzmann; Holger Kohlhammer; Carsten Schwaenen; Swen Wessendorf; Hans A. Kestler; Alexandra Schwoerer; Bettina Rau; Bernd Radlwimmer; Hartmut Döhner; Peter Lichter; Thomas Gress; Martin Bentz
Microarray and Serial Analysis of Gene Expression Analyses Identify Known and Novel Transcripts Overexpressed in Hematopoietic Stem Cells
Robert W. Georgantas, III; Vivek Tanadve; Matthew Malehorn; Shelly Heimfeld; Chen Chen; Laura Carr; Francisco Martinez-Murillo; Greg Riggins; Jeanne Kowalski; Curt I. Civin
Cell and Tumor Biology
Modulation of Tumor-host Interactions, Angiogenesis, and Tumor Growth by Tissue Inhibitor of Metalloproteinase 2 via a Novel Mechanism
Andrew L. Feldman; William G. Stetler-Stevenson; Nick G. Costouros; Vladimir Knezevic; Galina Baibakov; H. Richard Alexander, Jr.; Dominique Lorang; Stephen M. Hewitt; Dong-Wan Seo; Marshall S. Miller; Sarah O’Connor; Steven K. Libutti
Loss of Disialyl Lewisa, the Ligand for Lymphocyte Inhibitory Receptor Sialic Acid-Binding Immunoglobulin-Like Lectin-7 (Siglec-7) Associated with Increased Sialyl Lewisa Expression on Human Colon Cancers
Keiko Miyazaki; Katsuyuki Ohmori; Mineko Izawa; Tetsufumi Koike; Kensuke Kumamoto; Koichi Furukawa; Takayuki Ando; Makoto Kiso; Toshiyuki Yamaji; Yasuhiro Hashimoto; Akemi Suzuki; Aruto Yoshida; Makoto Takeuchi; Reiji Kannagi
Acquisition of Resistance to Butyrate Enhances Survival after Stress and Induces Malignancy of Human Colon Carcinoma Cells
Isabel López de Silanes; Nieves Olmo; Javier Turnay; Gonzalo González de Buitrago; Pablo Pérez-Ramos; Ana Guzmán-Aránguez; Marta García-Díez; Emilio Lecona; Myriam Gorospe; M. Antonia Lizarbe
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung Cancer
Makoto Maemondo; Yasuo Saijo; Ko Narumi; Toshiaki Kikuchi; Kazuhiro Usui; Ryushi Tazawa; Kunio Matsumoto; Toshikazu Nakamura; Katsunori Sasaki; Minoru Takahashi; Yoshiro Niitsu; Toshihiro Nukiwa
In Vitro and in Vivo Activity of the Maytansinoid Immunoconjugate huN901-N2′-Deacetyl-N2′-(3-Mercapto-1-Oxopropyl)-Maytansine against CD56+ Multiple Myeloma Cells
Pierfrancesco Tassone; Antonella Gozzini; Victor Goldmacher; Masood A. Shammas; Kathleen R. Whiteman; Daniel R. Carrasco; Cheng Li; Charles K. Allam; Salvatore Venuta; Kenneth C. Anderson; Nikhil C. Munshi
Prolonged Extracellular Signal-Regulated Kinase 1/2 Activation during Fibroblast Growth Factor 1- or Heregulin β1-Induced Antiestrogen-Resistant Growth of Breast Cancer Cells Is Resistant to Mitogen-Activated Protein/Extracellular Regulated Kinase Kinase Inhibitors
Jaideep V. Thottassery; Yanjie Sun; Louise Westbrook; Sarah S. Rentz; Marina Manuvakhova; Zhican Qu; Shanti Samuel; Ramanda Upshaw; Amanda Cunningham; Francis G. Kern
Distinct Responses of Xenografted Gliomas to Different Alkylating Agents Are Related to Histology and Genetic Alterations
Pascal Leuraud; Luc Taillandier; Jacques Medioni; Lucinda Aguirre-Cruz; Emmanuelle Crinière; Yannick Marie; Michèle Kujas; Jean-Louis Golmard; Adrien Duprez; Jean-Yves Delattre; Marc Sanson; Marie-France Poupon
Antiangiogenic and Antitumoral Activity of Phenyl-3-(2-Chloroethyl)Ureas: A Class of Soft Alkylating Agents Disrupting Microtubules That Are Unaffected by Cell Adhesion-Mediated Drug Resistance
Éric Petitclerc; Réna G. Deschesnes; Marie-France Côté; Claude Marquis; Richard Janvier; Jacques Lacroix; Élisabeth Miot-Noirault; Jean Legault; Emmanuelle Mounetou; Jean-Claude Madelmont; René C.-Gaudreault
Immunology
Endocrinology
Letters to the Editor
Advertisement
